People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Healthtech, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| WP CityMD Topco LLC | — | Healthtech | Growth/Late | $1.1B | $2.9B | 2021 |
| Progenity, Inc. | — | Biotechnology | Series C | $141.6M | $409.6M | 2019 |
| Anomaly Insights, Inc. | — | Other Technology | Series B | $30.2M | $87.6M | 2024 |
Jeffrey Alter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Alter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Alter | 2 | 3 |
| Stuart Ellman | 1 | 18 |
| Jason Black | 1 | 5 |
| Amr Kronfol | 1 | 5 |
| Richard Park | 1 | 4 |
| Harry Stylli | 1 | 3 |
| Samuel Nussbaum | 1 | 2 |
| Juliette Bolea | 1 | 2 |
| Thomas Carella | 1 | 2 |
| Sumit Aggarwal | 1 | 2 |
| Jonathan Hoffman | 1 | 2 |
| Jeffrey Ferrell | 1 | 2 |
| Howard Slutsky | 1 | 2 |
| Paul Vosters | 1 | 2 |
| Brian Kotzin | 1 | 2 |
| Nedal Shami | 1 | 2 |
| Jeffrey LeBenger | 1 | 2 |
| Adam Barrison | 1 | 2 |
| Eric d'Esparbes | 1 | 1 |
| Paul Hawran | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.